Literature DB >> 25746088

Setting the stage: local delivery of cytoreductive agents for the treatment of glioblastoma.

Steven N Kalkanis1.   

Abstract

Entities:  

Keywords:  convection-enhanced delivery; gene therapy; glioblastoma; local delivery; polymeric delivery

Mesh:

Substances:

Year:  2015        PMID: 25746088      PMCID: PMC4483040          DOI: 10.1093/neuonc/nov001

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

1.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

Review 2.  Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.

Authors:  M Kelly Nicholas; Rimas V Lukas; Steven Chmura; Bakhtihar Yamini; Maciej Lesniak; Peter Pytel
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

3.  Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques.

Authors:  Nathan McDannold; Costas D Arvanitis; Natalia Vykhodtseva; Margaret S Livingstone
Journal:  Cancer Res       Date:  2012-05-02       Impact factor: 12.701

4.  Magnetic resonance imaging and histopathology of cerebral gliomas.

Authors:  M Watanabe; R Tanaka; N Takeda
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

5.  Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital.

Authors:  Paul Mazaris; Xin Hong; David Altshuler; Lonni Schultz; Laila M Poisson; Rajan Jain; Tom Mikkelsen; Mark Rosenblum; Steven Kalkanis
Journal:  Clin Neurol Neurosurg       Date:  2014-03-12       Impact factor: 1.876

Review 6.  The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Authors:  Jeffrey J Olson; Lakshmi Nayak; D Ryan Ormond; Patrick Y Wen; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2014-04-17       Impact factor: 4.130

  6 in total
  1 in total

1.  Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.

Authors:  Tae Jin Lee; Mitra Nair; Yeshavanth Banasavadi-Siddegowda; Joseph Liu; Tejaswini Nallanagulagari; Alena Cristina Jaime-Ramirez; Jeffrey Yunhua Guo; Haroon Quadri; Jianying Zhang; Kurt H Bockhorst; Manish K Aghi; W Shawn Carbonell; Balveen Kaur; Ji Young Yoo
Journal:  Mol Cancer Ther       Date:  2019-03-29       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.